Ro / Custom Rx Treatment

What it is

A compounded prescription night treatment from Ro, prescribed after a free online visit, at $58 billed and shipped every two months — $29 a month, or $43 for a first order. A provider selects from a pool of seven published ingredients: tretinoin, azelaic acid, niacinamide, tranexamic acid, vitamin E, hyaluronic acid and ceramides. A paired moisturiser, Enriching Cream, is offered at $16 every two months.

Six words under the price

Every product in this register is a compounded drug. Compounded drugs are legal, they are prescribed under federal law, and they are not FDA-approved — they are mixed for an individual patient and are exempt from the premarket review that approved medicines undergo. That distinction matters, and almost nobody selling these products says it.

One company says it worse than nothing: Dermatica runs an 'FDA REGULATED' badge across four pages we read, in a scrolling strip beside 'CRUELTY FREE' and '100% VEGAN', on compounded formulas that are not FDA-approved.

Ro prints this immediately below the price, above the fold, before the first call to action:

Compounded medication. Not FDA-approved.

Ro, Custom Rx Treatment page, directly beneath the price

And the linked explanation does not soften it: compounded drugs 'are permitted to be prescribed under federal law, but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review'. That sentence appears three times across the safety pages. It is the single most useful sentence any company in this register has written about its own product, and it is a sentence that costs sales.

The safety information is built like a drug label

Beside tretinoin and azelaic acid on the ingredient list sits a link marked Important Safety Information. It leads to something no other brand in this register produces.

• ▸Who should not use it — including a pregnancy position that distinguishes oral tretinoin's established association with miscarriage and birth defects from the inconclusive topical evidence, and concludes it is best to be cautious.
• ▸A titration protocol: two to three nights a week as tolerated to begin with, then gradually to nightly.
• ▸Sun protection with numbers — at least SPF 15 for daily wear, at least SPF 30 in direct sunlight — plus protective clothing and avoidance.
• ▸Interactions, topical and oral: salicylic acid, sulfur and resorcinol on the skin; photosensitising antibiotics and blood pressure medicines by mouth.
• ▸Medical history to declare, down to lupus, albinism and porphyria.
• ▸Serious side effects listed separately from common ones, as a label does.
• ▸A route to report adverse events: 'Visit www.fda.gov/medwatch or call 1-800-FDA-1088.'
• ▸A link to full Prescribing Information, and a statement that this summary is not comprehensive.

The azelaic acid page carries its own detail, including that cold sores can be exacerbated and the cream should be kept off them — a caution we have not seen anywhere else in this category.

The most honest timeline we have assessed

This register's most repeated correction is about clocks. Musely headlines 88% of users seeing improvement by day thirty for a drug whose photoageing evidence is built on six-to-twelve-month trials. Dermatica promises visible results within twelve weeks on three separate indications, and within eight on a fourth.

Ro splits the promise into two, and tells you the slow half.

The staging around those numbers is equally good. Week one warns you may get dryness, redness and peeling, tells you not to panic, and offers the dilution trick — mixing the treatment into moisturiser — that experienced retinoid users learn the hard way. Weeks two to four set the expectation that it continues. And the page states outright that the product 'works best as a long-term treatment', which is the sentence Dermatica's rosacea page needed and did not have.

And then it will not tell you the number

Seven ingredients are named on this page. None of them carries a concentration. We checked the product page and both safety pages: there is not a single ingredient percentage anywhere.

For six of the seven that is a modest complaint. For tretinoin it is the whole question. Across the products in this register we have recorded tretinoin at 0.001%, 0.01%, 0.015%, 0.02%, 0.025%, 0.05%, 0.07% and 0.1% — a hundredfold spread, with the trial range for photoageing starting at 0.025%. A tretinoin formula is either inside that range or it is decorative, and nothing on this page or behind it lets a buyer tell which they have been sent.

The FAQ comes close and then stops: 'you will receive a detailed treatment plan that describes which ingredients are included in your custom formulation'. Which, not how much.

That is the shape of it. Dermatica will tell you there is 4% hydroquinone in the tube and then call a compounded formula FDA regulated. Ro will tell you the formula is not FDA-approved, hand you a proper drug label, show you how to report it to the regulator, and decline to say how much tretinoin is in it. Each has built precisely half of what a buyer needs, and it is not the same half.

Two smaller things worth crediting

The testimonials carry a footnote stating that they were submitted for Rory Nightly Defense, the product's previous name, that the formulas did not change at the rename, and that 'the members received their treatment at no cost for offering their photos and/or testimonials'. Disclosing that your testimonial-givers were paid in product is required, frequently buried, and here it is in plain language attached to the quotes.

And the pricing note, which is the only genuinely charming sentence we have quoted in twenty-five reviews: 'If you do the math, the trial offer is slightly more than 25% off—that's on purpose, because we like round numbers and we like you.' The arithmetic checks out: $58 less 25% is $43.50, and they charge $43. After Honeydew's four contradictory prices, a company flagging that its own discount is fractionally better than advertised is a pleasant thing to find.

If you are considering it

• ▸Read the linked safety information before you buy. It is better than most package inserts and it takes four minutes.
• ▸Ask for your tretinoin percentage, in writing, and ask again when the bottle arrives. Below 0.025% you are outside the photoageing trial range.
• ▸Ask which four of the seven you have actually been given — three of them are moisturiser.
• ▸If you are pregnant, breastfeeding or trying to conceive, Ro's own guidance says do not use it. Follow it.
• ▸Start at two to three nights a week as the safety page says, not nightly, whatever your enthusiasm.
• ▸Wear daily broad-spectrum SPF 30. The page tells you this properly; do it.
• ▸Judge tone and texture at week eight, and firmness at month eight. Those are the company's own numbers and they are honest ones.

Where we stand

At 68 this sits just under Dermatica's topical pages and comfortably above Curology and Agency, and it gets there from the opposite direction to all of them. Ro has built the disclosure this register keeps asking for on every axis except the one it is named after. It tells you what a compounded drug legally is. It gives you a real label. It tells you how to report it to the FDA. It tells you the firmness you want will take eight months. It even tells you the people in the photographs were given the product free.

Then it declines to print a percentage, and a buyer is left unable to answer the only question that determines whether the thing works: how much tretinoin is in this bottle. Every other company that hides that number also hides everything else, which makes it easy to characterise. Ro hides nothing else at all, which makes the omission stranger and, frankly, more frustrating.

Print the strengths on the treatment plan, and then on the page. Publish a fill weight so cost per application becomes computable. That is the entire distance between 68 and a recommendation, and this is a company that has already done the harder and more expensive parts.